Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.

Garber DA, O'Mara LA, Gangadhara S, McQuoid M, Zhang X, Zheng R, Gill K, Verma M, Yu T, Johnson B, Li B, Derdeyn CA, Ibegbu C, Altman JD, Hunter E, Feinberg MB.

J Virol. 2012 Dec;86(23):12605-15. doi: 10.1128/JVI.00246-12. Epub 2012 Sep 12.

2.

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.

Garber DA, O'Mara LA, Zhao J, Gangadhara S, An I, Feinberg MB.

PLoS One. 2009;4(5):e5445. doi: 10.1371/journal.pone.0005445. Epub 2009 May 6.

3.

Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

Norian LA, Rodriguez PC, O'Mara LA, Zabaleta J, Ochoa AC, Cella M, Allen PM.

Cancer Res. 2009 Apr 1;69(7):3086-94. doi: 10.1158/0008-5472.CAN-08-2826. Epub 2009 Mar 17.

4.

Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.

Vezys V, Masopust D, Kemball CC, Barber DL, O'Mara LA, Larsen CP, Pearson TC, Ahmed R, Lukacher AE.

J Exp Med. 2006 Oct 2;203(10):2263-9. Epub 2006 Sep 11.

5.

T cell-mediated delay of spontaneous mammary tumor onset: increased efficacy with in vivo versus in vitro activation.

O'Mara LA, Norian LA, Kreamalmeyer D, White JM, Allen PM.

J Immunol. 2005 Apr 15;174(8):4662-9.

6.

CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors.

Hanson HL, Kang SS, Norian LA, Matsui K, O'Mara LA, Allen PM.

J Immunol. 2004 Apr 1;172(7):4215-24.

7.

Pulmonary tumors inefficiently prime tumor-specific T cells.

O'Mara LA, Allen PM.

J Immunol. 2004 Jan 1;172(1):310-7.

8.

Supplemental Content

Loading ...
Support Center